Search Within

Neerav Shukla

Formats
  1. Journal Article (77)
  2. Meeting Abstract (74)
  3. Review (5)
  4. Research Letter (3)
  5. Editorial (2)
Groups
  1. Center for Hematologic Malignancies (161)
  2. Hematologic Malignancies Service (161)
  3. Pediatric Leukemia (161)
  4. Pediatrics, Department of (161)
  5. GSK Faculty (88)
  6. Tow Center for Developmental Oncology (TCDO) (83)

More Groups

People
  1. Marc Ladanyi (42)
  2. Peter Steinherz (36)
  3. Rachel Kobos (31)
  4. Andrew Kung (27)
  5. Michael Berger (22)
  6. Michael Walsh (19)

More People

Years
  1. 2025 (5)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (14)
  5. 2021 (12)
  6. 2020 (11)

More Years

Publications
  1. Blood (27)
  2. Pediatric Blood and Cancer (20)
  3. Journal of Clinical Oncology (16)
  4. Clinical Cancer Research (8)
  5. JCO Precision Oncology (8)
  6. Cancer Research (7)

More Publications

Publishers
  1. American Society of Hematology (33)
  2. American Society of Clinical Oncology (24)
  3. Wiley Periodicals, Inc (20)
  4. American Association for Cancer Research (18)
  5. Nature Publishing Group (12)
  6. Oxford University Press (10)

More Publishers

Results (161)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects
    Meeting Abstract

    Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) T cells targeting the CD19 antigen for the treatment of pediatric relapsed B cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Kobos, R.; Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Renaud, T. M.; Shukla, N.; Steinherz, P. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Utility of combined DNA and RNA next generation sequencing in leukemias for identification of prognostic and therapeutically relevant genomic alterations in clinical practice
    Meeting Abstract

    Coombs, C. C.; Viny, A. D.; He, J.; Kobos, R.; Lipson, D.; Shukla, N.; Knapp, K. M.; Otto, G.; Abdel-Wahab, O.; Stein, E. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • High-dose cyclophosphamide for the treatment of refractory T-cell acute lymphoblastic leukemia in children
    Journal Article

    Kobos, R.; Shukla, N.; Renaud, T.; Prockop, S. E.; Boulad, F.; Steinherz, P. G.
    Journal of Pediatric Hematology/Oncology (2014)

    Fulltext@MSK | Save
  • Prolonged hypogammaglobulinemia in pediatric lymphoma patients after rituximab therapy
    Meeting Abstract

    Terry, W.; Shukla, N.; Renaud, T.; Kernan, N.; Chaudhuri, J.; Steinherz, P.; Kobos, R.
    Pediatric Blood and Cancer (2014)

    Fulltext@MSK | Save
  • A recurrent point mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma
    Meeting Abstract

    Kohsaka, S.; Shukla, N.; Ameur, N.; Lim, D. ; Viale, A.; Socci, N.; Qin, L. X.; Sciot, R.; Bridge, J.; Singer, S.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
    Journal Article

    Kohsaka, S.; Shukla, N.; Ameur, N.; Ito, T.; Ng, C. K. Y.; Wang, L.; Lim, D. ; Marchetti, A.; Viale, A.; Pirun, M.; more...
    Nature Genetics (2014)

    Fulltext@MSK | Save
  • Busulfan, melphalan, and thiotepa conditioning for allogeneic hematopoietic stem cell transplantation (HSCT) of pediatric patients with acute leukemia and central nervous system (CNS) disease
    Meeting Abstract

    Forlenza, C. J.; Kobos, R.; Kernan, N. A.; Scaradavou, A.; Prockop, S. E.; Curran, K.; Shukla, N.; Steinherz, P. G.; O'reilly, R.; Boulad, F.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia
    Journal Article

    Shukla, N.; Kobos, R.; Renaud, T.; Steinherz, L. J.; Steinherz, P. G.
    Pediatric Blood and Cancer (2014)

    Fulltext@MSK | Save
  • Biomarkers in Ewing sarcoma: The promise and challenge of personalized medicine. A report from the children's oncology group
    Journal Article

    Shukla, N.; Schiffman, J. D.; Reed, D.; Davis, I. J.; Womer, R. B.; Lessnick, S. L.; Lawlor, E. R.
    Frontiers in Oncology (2013)

    Fulltext@MSK | Save